The use of Risperdal may increase the risk of Gynecomastia, which is when young males experience large breast growth.
Risperdal (Risperidone), a product of the mega manufacturer Johnson & Johnson, is an atypical antipsychotic drug that is typically used to treat schizophrenia, bipolar disorder, dementia, autism and Tourette syndrome. Risperdal has endured harsh criticism for marketing treatment in children before 2007 when FDA finally approved the drug for treatment in children. In 2010 Risperdal was linked to the side effect gynecomastia, which is when young males experience large breast growth. This particular Risperdal side effect not only has a physical impact on its victims, but a gynecomastia diagnosis can also play a major emotional toll on its victims.
Johnson & Johnson is being sued because they marked Risperdal as a treatment in children before the FDA approved them to do so. The FDA did not approve Risperdal in children until 2007, but sources say that Risperdal had been pushed as a viable treatment for children since 2003.
In 2010, Risperdal lawsuits began to surface after young men who took the drug began to develop breasts.
Many young men who have developed gynecomastia after taking the drug have begun to file Risperdal lawsuits against the drug manufacturer, Johnson & Johnson. Currently, there are multiple Risperdal gynecomasita litigations underway, with the projection of many more future claims. If you or a loved one suffered has suffered from gynecomastia from taking Risperdal before the age of 21, act now by filling out the form above and you may be eligible to get the financial compensation you deserve.